期刊文献+

72例银屑病患者生活质量调查及影响因素研究 被引量:5

Study on the Quality of Life and Influencing Factors in 72 Patients with Psoriasis
暂未订购
导出
摘要 目的:探讨银屑病对患者生活质量的影响状况及对生活质量主要影响因素的分析。方法:采用皮肤病生活质量指数(dermatology life quality index,DLQI)和银屑病无能指数(psoriasis disability index,PDI)量表调查72例银屑病患者,记录患者的一般情况;同时采用银屑病面积和严重程度指数(psoriasis area and severity index,PASI)评分评判患者病情的严重程度,采用方差分析比较不同病情严重程度患者间生活质量的差异。结果:DLQI与PDI调查结果均显示银屑病患者在工作学习方面的分值(DLQI:1.69±1.31,PDI:2.92±2.61)最高,受到影响最大;PDI量表显示男性患者总分平均值高于女性患者,差异有统计学意义(t=2.73,P<0.05),DLQI与PDI量表均显示重度(PASI>10)患者的总分平均值高于轻度(0<PASI≤5)患者,差异有统计学意义(DLOQ:t=0.72;PDI:t=1.45,P值均<0.05)。结论:银屑病为一种身心性疾病,患者在工作学习方面受到的影响较明显;与患者生活质量最为相关的是病情的严重程度,病情严重程度越高的患者生活质量受到的影响越大。 Objective:To study the quality of life of patients with psoriasis and the influencing factors of patients' quality of life. Methods: The Dermatology Life Quality Index ( DLQI ) and Psoriasis Disability Index (PDI) were adopted to evaluate the life quality in 72 patients with psoriasis. Severity of psoriasis was assessed by the Psoriasis Area Severity Index (PASI). The impact of severity of psoriasis on quality of life in psoriasis patients was analyzed by variance analysis. Results : The aspect of work and study in patients had the highest scores in both DLQI ( 1.69 ± 1.31 ) and PDI(2.92±2.61 ) ;The PDI scores were significantly higher in males than those in females (t = 2.73, P 〈 0. 05 ), the DLQI and PDI scores were also higher in severe patients (PASI 〉 10) than those in mild patients (0 〈 PASI ≤ 5 ) ( DLQI : t = 0.72 ; PDI : t = 1.45 ; both P 〈 0. 05 ). Con- clusion:Psoriasis is a physical and mental disorders, it affects the quality of life of patients especially their work and study. The most important influencing factor is the severity of the disease. The more severe the disease is, the greater impact on the patients.
出处 《皮肤性病诊疗学杂志》 2013年第5期314-317,共4页 Journal of Diagnosis and Therapy on Dermato-venereology
关键词 银屑病 生活质量 影响因素 Psoriasis Life quality Influencing factors
  • 相关文献

参考文献7

  • 1王艳芳,林仕英,张文君,师晋萍,林壬娇,何玉清.142例银屑病患者的心理健康状况调查及心理护理要素分析[J].岭南皮肤性病科杂志,2009,16(5):318-319. 被引量:9
  • 2Finlay AY,Khan GK.Dermatology Life Quality Index(DLQI)-a simple practical measure for routine clinicaluse[J].Clin Exp Dermatol,1994,19(3):210-216.
  • 3Finlay AY,Coles EC.The effect of severe psoriasis on thequality of life of 369 patients[J].Br J Dermatol,1995,132(2):236-244.
  • 4He Z,Lu C,Basra MK,et al.Psychometric properties ofthe Chinese version of Dermatology Life Quality Index(DLQI)in 851 Chinese patients with psoriasis[J].J EurAcad Dermatol Venereol,2011,27(1):109-115.
  • 5Shikiar R,Bresnahan BW,Stone SP,et al.Validity andreliability of patient reported outcomes used in psoriasis:results from two randomized clinical trials[J].HealthQual Life Outcomes,2003,1:53.
  • 6O'Neill P,Kelly P.Postal questionnaire study of disabilityin the community associated with psoriasis[J].BMJ,1996,313(7062):919-921.
  • 7张敏,汪盛,张谊之,黎静宜.银屑病患者生活质量调查[J].临床皮肤科杂志,2006,35(6):370-372. 被引量:46

二级参考文献13

  • 1魏双平,四荣联,张晓光.银屑病患者心理特征及影响因素分析[J].岭南皮肤性病科杂志,2003,10(4):229-231. 被引量:2
  • 2李玉华,胡英,谢继璜,李雪.80例重症银屑病患者的心理分析及护理干预[J].岭南皮肤性病科杂志,2006,13(2):174-175. 被引量:16
  • 3金华 张明园.中国正常人SCL-90评定结果初步分析[J].中国神经精神疾病杂志,1986,12(5):260-260.
  • 4Amold SB, Birrren JE, Fisher LM, et al. The concept and Measurement of Quality of Life in the Frail Elderly[ M]. califormia : Academic press Inc, 1991:50 - 74.
  • 5Krueger G,Koo J,Lebwohl M,et al.The impact of psoriasis on quality of lifer results of a 1998 National Psoriasis Foundation patient-membership survey[J].Arch Dermatol,2001,137(3):280-284.
  • 6Mazzotti E,Picardi A,Sampogna F,et al.Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis[J].Br J Dermatol,2003,149(2):318-322.
  • 7Zaghloul SS,Goodfield MJ.Objective assessment of compliance with psoriasis treatment[J].Arch Dermatol,2004,140(4):408-414.
  • 8Feldman SR,Menter A,Koo JY.Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis[J].Br J Dermatol,2004,150(2):317-326.
  • 9Menter A,Kosinski M,Bresnahan BW,et al.Impact of efalizumab on psoriasis-specific patient-reported outcomes.Results from three randomized,placebo-controlled clinical trials of moderate to severe plaque psorlasis[J].J Drugs Dermatol,2004,3(1):27-38.
  • 10Feldman SR,Gordon KB,Bala M,et al.Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis:a double -blind placebo-controlled trial[J].Br J Dermatol,2005,152(5):954-960.

共引文献52

同被引文献43

引证文献5

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部